| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917889 | Radiotherapy and Oncology | 2015 | 5 Pages |
Abstract
Daily anatomical changes hardly influence the target dose distribution for H&N VMAT treatments according to TPS recalculations. Including CBCT information in EPID dose reconstructions slightly improves the agreement with TPS calculations.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Roel A. Rozendaal, Ben J. Mijnheer, Olga Hamming-Vrieze, Anton Mans, Marcel van Herk,